Table 5.
Clinical and Demographic Characteristics of Clusters
| Cluster 1 (n = 186) | Cluster 2 (n = 92) | Cluster 3 (n = 120) | Cluster 4 (n = 76) | |
|---|---|---|---|---|
| Age (median, IQR) | 73 (66‐81) | 77 (69‐84) | 72 (62‐78) | 70 (61‐77) |
| TTR >75% (n, %) | 132 (71.0) | 47 (51.1) | 64 (53.3) | 28 (36.8) |
| Male (n, %) | 121 (65.1) | 60 (65.2) | 78 (65.0) | 37 (48.7) |
| Caucasian (n, %) | 180 (96.8) | 79 (87.8) | 103 (86.6) | 61 (81.3) |
| AF (n, %) | 127 (68.3) | 68 (73.9) | 75 (62.5) | 47 (61.8) |
| VTE (n, %) | 43 (23.1) | 21 (22.8) | 34 (28.3) | 22 (29.0) |
| Other (n, %) | 16 (8.6) | 3 (3.3) | 11 (9.2) | 7 (9.2) |
| CHADS2 (mean, SD)a | 2.1 (1.2) | 2.3 (1.4) | 2.3 (1.4) | 2.0 (1.0) |
| CHA2DS2VASc (mean, SD)a | 3.4 (1.3) | 3.6 (1.6) | 3.4 (1.6) | 3.4 (1.2) |
| HAS‐BLED (mean, SD) | 1.7 (1.0) | 1.9 (0.9) | 1.8 (0.9) | 1.8 (0.9) |
| CCI 10 year mortality (mean, SD) | 0.4 (0.3) | 0.3 (0.3) | 0.3 (0.3) | 0.3 (0.3) |
| SAME‐TTR (mean, SD) | 1.1 (0.9) | 1.4 (1.1) | 1.4 (1.1) | 1.9 (1.2) |
a
AF patients only.